STAT November 6, 2025
Daniel Payne, Elaine Chen, Damian Garde, Katie Palmer

How many more people will get scripts? And what will that mean for Eli Lilly and Novo Nordisk?

WASHINGTON — The Trump administration’s deal to expand access to and lower the cost of weight loss drugs has left industry leaders, public health experts, and patients with a host of open questions.

The administration’s agreements with Eli Lilly and Novo...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Insurance, Medicaid, Medicare, Pharma, Pharma / Biotech
Federal Discretionary Spending To Address Substance Use Disorders: How Big A Shift?
White House and Congress Turn Focus to Health Policy
CVS accused of shutting out rival pharmacy hubs in House Judiciary investigation
OIG Recounts Historic Recovery Numbers in Its Latest Semiannual Report to Congress
What is included in Trump’s “Great Healthcare Plan”?

Share Article